A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers
Clinical trial NCT02919696 · COMPLETED
Trial details
- NCT number
- NCT02919696
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2018-11-23
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.